Literature DB >> 22309616

Acute respiratory infections due to enterovirus 68 in Yamagata, Japan between 2005 and 2010.

Tatsuya Ikeda1, Katsumi Mizuta, Chieko Abiko, Yoko Aoki, Tsutomu Itagaki, Fumio Katsushima, Yuriko Katsushima, Yoko Matsuzaki, Naoko Fuji, Tadatsugu Imamura, Hitoshi Oshitani, Masahiro Noda, Hirokazu Kimura, Tadayuki Ahiko.   

Abstract

To clarify the epidemiology of enterovirus 68 (EV68), which is one of the most rarely identified enteroviruses, virus isolation and molecular screening using RT-PCR was performed on 6307 respiratory specimens collected at pediatric clinics in Yamagata, Japan between 2005 and 2010. In the years 2005-2009, 10, 1, 2, 0, and 2 (40) EV68-positive cases, respectively, were identified by RT-PCR. In 2010, 40 cases were identified altogether: 2 by isolation only, 26 by RT-PCR only, and 12 by both isolation and RT-PCR. Phylogenetic analysis indicated that plural genetically distinct clusters co-circulated. These results suggest that that difficulty in EV68 isolation leads to an underestimation of the prevalence of EV68 infections.
© 2012 The Societies and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22309616     DOI: 10.1111/j.1348-0421.2012.00411.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  39 in total

1.  Molecular epidemiology of enterovirus D68 from 2013 to 2014 in Philippines.

Authors:  Yuki Furuse; Natthawan Chaimongkol; Michiko Okamoto; Tadatsugu Imamura; Mariko Saito; Raita Tamaki; Mayuko Saito; Socorro P Lupisan; Hitoshi Oshitani
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

2.  Enterovirus 68 in pediatric patients hospitalized for acute airway diseases.

Authors:  Fanny Renois; Alexis Bouin; Laurent Andreoletti
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

3.  In Vitro Efficacy of Antiviral Compounds against Enterovirus D68.

Authors:  Eric Rhoden; Mingyu Zhang; W Allan Nix; M Steven Oberste
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

4.  Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3.

Authors:  Zichun Xiang; Linlin Li; Xiaobo Lei; Hongli Zhou; Zhuo Zhou; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

Review 5.  Enterovirus D68-Associated Community-Acquired Pneumonia in the Pediatric Age Group.

Authors:  Samantha Bosis; Susanna Esposito
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

6.  Molecular Evolution and Intraclade Recombination of Enterovirus D68 during the 2014 Outbreak in the United States.

Authors:  Yi Tan; Ferdaus Hassan; Jennifer E Schuster; Ari Simenauer; Rangaraj Selvarangan; Rebecca A Halpin; Xudong Lin; Nadia Fedorova; Timothy B Stockwell; Tommy Tsan-Yuk Lam; James D Chappell; Tina V Hartert; Edward C Holmes; Suman R Das
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  A reverse genetics system for enterovirus D68 using human RNA polymerase I.

Authors:  Minglei Pan; Shuai Gao; Zhenwei Zhou; Keke Zhang; Sihua Liu; Zhiyun Wang; Tao Wang
Journal:  Virus Genes       Date:  2018-05-17       Impact factor: 2.332

8.  3C Protease of Enterovirus D68 Inhibits Cellular Defense Mediated by Interferon Regulatory Factor 7.

Authors:  Zichun Xiang; Lulu Liu; Xiaobo Lei; Zhuo Zhou; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

9.  National surveillance for non-polio enteroviruses in Canada: Why is it important?

Authors:  T F Booth; E Grudeski; A McDermid
Journal:  Can Commun Dis Rep       Date:  2015-02-20

10.  Enterovirus D68 Protease 2Apro Targets TRAF3 To Subvert Host Innate Immune Responses.

Authors:  Jun Kang; Zheng Pang; Zhenwei Zhou; Xianhuang Li; Sihua Liu; Jinyan Cheng; Peiyuan Liu; Wenjie Tan; Zhiyun Wang; Tao Wang
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.